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Abstract
Background: Transcranial direct current stimulation (tDCS) is a promising new technique to optimize the effect of
regular Speech and Language Therapy (SLT) in the context of aphasia rehabilitation. The present study focuses on
the effect of tDCS provided during SLT in the sub-acute stage after stroke. The primary aim is to evaluate the
potential effect of tDCS on language functioning, specifically on word-finding, as well as generalization effects to
verbal communication. The secondary aim is to evaluate its effect on social participation and quality of life, and its
cost-effectiveness.
Methods: We strive to include 58 stroke patients with aphasia, enrolled in an inpatient or outpatient stroke
rehabilitation program, in a multicenter, double-blind, randomized controlled trial with two parallel groups and
6 months’ follow-up. Patients will participate in two separate intervention weeks, with a pause of 2 weeks in
between, in the context of their regular aphasia rehabilitation program. The two intervention weeks comprise daily
45-minute sessions of word-finding therapy, combined with either anodal tDCS over the left inferior frontal gyrus
(1 mA, 20 minutes; experimental condition) or sham-tDCS over the same region (control condition). The primary
outcome measure is word-finding. Secondary outcome measures are verbal communication, social participation,
quality of life, and cost-effectiveness of the intervention.
Discussion: Our results will contribute to the discussion on whether tDCS should be implemented in regular
aphasia rehabilitation programs for the sub-acute post-stroke population in terms of (cost-)effectiveness.
Trial registration: Nederlands Trail Register: NTR4364. Registered on 21 February 2014.
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Background
Aphasia is present in about 30 % of patients immediately
after stroke [1]. In the first weeks and months, consider-
able recovery may occur; however, about 20 % are left
with chronic deficits at 6 months post stroke [2, 3].
There is increasing support for the efficacy of Speech
and Language Therapy (SLT) in order to diminish the
language and communication deficits that people with
aphasia encounter [4]; however, it remains a challenge to
optimize the effect of aphasia therapy.
Transcranial direct current stimulation (tDCS) is a
promising new technique to optimize the effect of regu-
lar SLT in the context of aphasia rehabilitation [5]. It is
safe and easy to apply and has limited side effects [6].
tDCS modulates cortical excitability by delivering weak
electric currents to the cortex via two electrodes applied
to the skull [7]. The effect of tDCS depends on the po-
larity of the electrodes: anodal tDCS enhances neuronal
excitability while cathodal tDCS diminishes neuronal
excitability. This effect is related to a change in the
resting membrane potential. Anodal tDCS leads to de-
polarization, increasing the chance for an action potential,
and cathodal tDCS leads to hyper-polarization [8, 9].
tDCS is also related to neuroplasticity. Specifically,
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processes like long-term potentiation and secretion of
brain-derived neurotrophic factor (BDNF) are associated
with tDCS application [10]. The potential benefits of
tDCS applied during SLT have been described since
2008 [5, 11–17]. However, these studies have some
methodological limitations such as small sample size
and lack of randomization.
The application of tDCS to enhance the effect of SLT
is associated with the notion that tDCS may have a role
in rebalancing the activity of both hemispheres post
stroke. Language processing is strongly lateralized to the
left hemisphere (LH), at least in right-handed healthy in-
dividuals [18–21]. After LH damage and aphasia, the
right hemisphere (RH), may show increased activity.
Whether this increased activity in the RH is adaptive or
maladaptive, is an unresolved issue [22–24]. However,
most studies indicate that, in the long term, LH perile-
sional recruitment is associated with better aphasia re-
covery, while RH recruitment is related to incomplete
recovery [25–27]. In line with these observations, most
studies use tDCS as a tool to promote LH perilesional
recruitment.
Across studies, different electrode configurations are
used to promote LH perilesional recruitment. In some
studies anodal tDCS [13, 15, 16] is applied either to the
left inferior frontal gyrus (IFG: Broca’s area) or to the left
superior temporal gyrus (Wernicke’s area), while other
studies use cathodal tDCS to inhibit the RH homolog
areas, so as to disinhibit the LH [14, 28]. Few studies
use an individual approach for electrode configurations
[11, 29]. Anodal tDCS to the left IFG, with the cathode
placed on the contralateral supra-orbital region, is the
most common configuration, which has been supported
by studies investigating this further with functional
magnetic resonance imaging (fMRI) [30, 31] and com-
puter modeling [32]. Predominantly, tDCS studies choose
word-finding therapy as the behavioral treatment compo-
nent. Irrespective of electrode configurations, studies
point to an additional effect of tDCS on language func-
tioning, when combined with SLT [5, 11–17, 29].
Studies evaluating tDCS in sub-acute aphasia rehabili-
tation are limited [26]. Evaluating the potential of tDCS
in patients with sub-acute aphasia is important, as the
larger proportion of language treatment for stroke pa-
tients is provided in the sub-acute phase, during the first
weeks and months post stroke. During these first months,
the recovery rate is highest [33].
Therefore, the aim of the present study is to investi-
gate the effect of tDCS in sub-acute stroke patients with
aphasia who are enrolled in regular stroke rehabilitation
services. In line with studies applying tDCS in the chronic
stage, we use the most common electrode configuration,
i.e., anodal tDCS over the left IFG as compared to sham-
tDCS, in combination with disorder-oriented aphasia
therapy, aimed at word-finding. The cathode is placed on
the contralateral supra-orbital region.
Objective
The present study focuses on the effect of tDCS provided
during SLT in the sub-acute stage after stroke. The pri-
mary aim is to evaluate the effect of tDCS on language
functioning. The primary outcome measure is word-
finding. Secondary outcome measures are verbal commu-
nication, social participation, quality of life, and the
cost-effectiveness of the intervention.
Methods
Study design and procedure
The study is a multicenter, double-blind, randomized
controlled trial with two parallel groups and 6-month
follow-up. Patients will participate in two separate inter-
vention weeks, with a pause of 2 weeks in between, in
the context of regular aphasia rehabilitation (see Fig. 1).
During each intervention week, regular SLT sessions are
replaced by daily 45-minute sessions of word-finding
therapy, combined with either anodal tDCS over the left
IFG (1 mA, 20 minutes; experimental condition) or
sham-tDCS over the same region (control condition).
The cathode is placed on the contralateral supra-orbital
region. To our knowledge, a parallel design with two sep-
arate intervention weeks has not been used before in the
tDCS literature. This design allows measurements before
and after each intervention week, thus providing informa-
tion on the recovery pattern over time within one subject.
All other therapies in the participant’s stroke rehabili-
tation program, such as physical therapy or occupational
therapy remain unchanged and are offered following the
stroke rehabilitation protocol of each participating re-
habilitation center.
Setting and study population
Stroke patients with aphasia, who are receiving regular
aphasia therapy, will be screened for eligibility and start
the intervention between 3 weeks and 3 months after
their stroke. These patients are enrolled in regular stroke
rehabilitation (inpatient and outpatient services) in four
rehabilitation centers in the Netherlands: Rijndam Re-
habilitation (Rotterdam), Libra Rehabilitation (Tilburg
and Eindhoven), Revant Rehabilitation (Breda) and De
Hoogstraat Rehabilitation (Utrecht). Table 1 lists the in-
clusion and exclusion criteria. We strive to include 58
patients, based on a power analysis (see section Data
analysis). Before inclusion, all participants need to sign
the informed consent form. Patient information is pro-
vided orally as well as in written form, with extra versions
in an aphasia-friendly format. This study has been ap-
proved by the Medical Ethics Committee (MEC) of the
Erasmus MC, University Medical Center Rotterdam. The
Spielmann et al. Trials  (2016) 17:380 Page 2 of 7
researcher will report serious adverse events (SAE) to the
MEC and SAEs are handled according to the WMO
(“Wet Medisch-wetenschappelijk Onderzoek”), the Dutch
law for medical scientific research. tDCS is known to be a
safe intervention with minimal side effects [6]. Partici-
pants who develop post-stroke epileptic seizures before
the end of the 4-week intervention will be withdrawn
from the intervention, but not from the study; all assess-
ments will be completed (intention-to-treat analysis).
Randomization and blinding
Randomization is stratified per center of inclusion. To
randomize participants to the experimental or control
condition, we use a list of five-number codes, provided
by the manufacturer of the stimulation device. Half of
these codes activate the device to deliver anodal tDCS
(experimental condition) and half of these codes deliver
sham-tDCS (control condition). Codes are block ran-
domized with a block size of four on the basis of a
computer-generated sequence and then concealed in
consecutively numbered, sealed, opaque envelopes. The
envelope is opened at the start of the first intervention
session. The participant’s unique five-number code is used
to start the tDCS device, which then provides either
real stimulation or sham as related to the code. The
randomization and the preparation of the envelopes are
done by a researcher (MH) of our research team, who
is not involved in assessments and training of the pa-
tient. The key to the five-number codes is also kept by
this researcher (MH). Consequently, the participants,
their SLTs and the trial coordinator are blinded to
treatment condition.
Fig. 1 Study design with two separate intervention weeks
Table 1 Inclusion and exclusion criteria
Inclusion criteria
1. Aphasia after stroke
2. Less than 3 months post onset
3. Age 18–80 years
4. Near-native speaker of Dutch
5. Being right-handed
6. Able to participate in intensive therapy
Exclusion criteria
1. Subarachnoid hemorrhage
2. Prior stroke resulting in aphasia
3. Brain surgery in the past
4. Epileptic activity in the past 12 months
5. Premorbid (suspected) dementia
6. Premorbid psychiatric disease affecting communication (for example,
personality disorder)
7. Excessive use of alcohol or drugs
8. Presence of a cardiac pacemaker
9. Severe non-linguistic cognitive disturbances impeding language
therapy
10. Global aphasia, defined as Shortened Token Test score <9 [50] and
score 0 on the Aphasia Severity Rating Scale [41]
11. Severe Wernicke’s aphasia, defined as Shortened Token Test score
<9 and score 0–1 on the Aphasia Severity Rating Scale
12. Residual aphasia, defined as Shortened Token Test score >28 and
score 4–5 on the Aphasia Severity Rating Scale and Boston Naming
Test score >150 [40]
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Intervention
In each intervention week, regular SLT sessions are re-
placed by daily 45-minute sessions of word-finding
therapy, combined with either anodal tDCS over the
left IFG (1 mA, 20 minutes; experimental condition) or
sham-tDCS over the same region (control condition).
Therapy is provided by speech and language therapists
of the participating centers. The cathode is placed on
the contralateral supra-orbital region. The intensity of
1 mA tDCS for 20 minutes and the frequency of five
sessions per week is in line with most studies applying
tDCS in the chronic stage [11, 13–16]. tDCS is com-
bined with word-finding therapy, because most people
with aphasia have word-finding difficulties [34]. The
word-finding therapy protocol is based on Cueing Hier-
archy Therapy [35]. The participant’s task is to name a
picture and, based on the protocol, the therapist uses
cueing techniques to help the participant to retrieve
and produce the target word correctly. The cue of low
stimulus power is presented first, followed by increas-
ingly powerful cues until the correct word is retrieved
and produced. Basically, the following cueing hierarchy
is used: (1) “What is this?”(e.g., show picture of a tree),
(2) “Can you write the word down?”, (3) graphemic
cueing (e.g., provide the number of letters), (4) phono-
logical cueing (e.g., provide the first sound, /t/), (5) se-
mantic associations (e.g., “can you tell where you can
find these”), (6) therapist says the word (e.g., “tree”), (7)
repetition of the target word.
As the relative power of the cues differs across partici-
pants with aphasia, the exact cueing hierarchy is person-
alized. For each picture, even if the picture is named
without cues, the participant is encouraged to write or
copy the correct word form or, in case of inability to
write, to perform an anagram task. The rationale for in-
corporating production of the written word, is the evi-
dence that activating the written word has a beneficial
effect on retrieving spoken words [36].
To ensure relevance of the training material for each
participant, stimuli are selected on the basis of individ-
ual naming performance at baseline using the European
Data Bank (EDB) for oral picture naming [37]. The
first 68 items the participant is unable to name cor-
rectly within 20 s are selected. These items are divided
in two sets of 34 items, matched for word length and
word frequency: a therapy set, trained during the
word-finding therapy, and a control set, to evaluate
generalization effects to untrained items. In the first
session 10 items are trained. Then, during each session
new items are added, with eight new items in the sec-
ond session; six new items in the third and fourth ses-
sion, and four new items in the final session. For the
second intervention week a new training set is selected
in the same way.
tDCS
The DC Stimulator PLUS (produced by Eldith), certified
as a medical device, class IIa, by the European Union
Notified Body 0118 (CE 118), is used in the authorized
form. Two electrodes (5 x 7 cm) are placed on the head
and fixed with elastic tape; electrode placement is guided
by the international 10-10 electroencephalogram (EEG)
system and previous studies [15, 38, 39]. The anode is
placed on the left IFG, localized as F5, and the cathode
is placed on the contralateral supra-orbital region, local-
ized as Fp2. Participants in the experimental condition
receive active stimuli of 1 mA during 20 minutes. The
stimulation is automatically activated with a fade in of
15 s and after 20 minutes the stimulation is automatic-
ally deactivated, with a fade out of 15 s. Participants in
the control condition receive inactive stimulation (sham-
tDCS), i.e., at first the stimulation is automatically acti-
vated with a fade in of 15 s, and then the stimulation is
deactivated after 30 s, with a fade out of 15 s. Both the
patient and the therapist are blinded for stimulation
condition. The electrodes are not removed until comple-
tion of the 45-minute therapy session.
Measurement instruments
Table 2 gives an overview of the measurement instruments
being used. The primary outcome measure is the score on
the Boston Naming Test (BNT) [40], to assess picture-
naming. Secondary outcome measures are chosen to
evaluate generalization of treatment effects to verbal
communication: the Aphasia Severity Rating Scale (ASRS)
[41] to assess spontaneous speech and the Amsterdam
Nijmegen Everyday Language Test (ANELT) [42] as a
measure for verbal communication in everyday life. Other
secondary outcome measures are chosen to evaluate qual-
ity of life (EuroQol-5D, [43]; Stroke and Aphasia Quality
Table 2 Measurement instruments
Language and communication tests
Boston Naming Test (BNT) [40]
Aphasia Severity Rating Scale (ASRS) [41]
Amsterdam Nijmegen Everyday Language Test (ANELT) [42]
Shortened Token Test [50]
Quality of life questionnaires
EuroQol-5D (EQ-5D) [43]
Stroke and Aphasia Quality Of Life questionnaire (SAQOL) [44, 45]
Other tests
Community Integration Questionnaire (CIQ) [46]
Cost Analysis Questionnaire [47–49]
Barthel Index [51]
Edinburgh Handedness Inventory
Wong-Baker Faces pain rating scale [52]
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Of Life questionnaire (SAQOL), [44, 45]), social participa-
tion (Community Integration Questionnaire, [46]), and
cost-effectiveness (Cost Analysis Questionnaire, [47–49]).
The primary outcome measure, BNT, is assessed before
and after each intervention week (T1, T2, T3, T4) and at
6 months’ follow-up (T5); see Fig. 2. The secondary out-
come measures are assessed before the first intervention
week and after the second intervention week (T1, T4)
and at 6 months (T5). The EuroQol-5D (EQ-5D) and
the Cost Analysis Questionnaire are used to evaluate
cost-effectiveness during the 4-week intervention period
and during the follow-up period.
Baseline assessments (T1) include handedness (Edinburgh
Handedness Inventory), aphasia severity (Shortened Token
Test) [50] and overall functioning (Barthel Index) [51]. To
register potential adverse effects, participants are asked
to rate their discomfort immediately after each therapy
session on the Wong-Baker Faces pain rating scale, a
visual analog scale designed for patients with limited
verbal skills [52].
To summarize the present study protocol, please see
Additional file 1 for an overview of enrollment, interven-
tion and measurement instruments, and see Additional
file 2 for an overview of the Standard Protocol Items:
Recommendations for Interventional Trials (SPIRIT)
checklist.
Sample size
The power calculation is based on the results of a ran-
domized controlled trial by Baker et al. [11] including
stroke patients in the chronic phase. In this study the
group of aphasia patients trained with tDCS improved 2.1
points more than a sham-control group on a picture-
naming test. Cohen’s d effect size was 0.22, which is equal
to a Cohen’s f of 0.11. For the present study we calculated
that, using a study design with two groups and four re-
peated measurements, a within-patient correlation of 0.75,
an alpha of 0.05, a power of 0.80 and a Cohen’s f effect size
of 0.11, we need a total group of 58 patients (29 patients
in each treatment arm).
Data analysis
Once randomized, each patient will be analyzed in the
group to which they were assigned, independent of po-
tential drop-out or compliance to the protocol, accord-
ing to the intention-to-treat principle. Potential baseline
differences between the groups will be tested using inde-
pendent t tests for continuous variables, the Mann-Whitney
U test for ordinal variables, and chi-square tests for categor-
ical variables.
Outcomes of the measures over time will be com-
pared for the experimental condition versus the control
condition using repeated measurements analysis. This
Fig. 2 Measurement instruments and test moments
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analysis takes into account the correlation of repeated
measurements within the same patients and it can han-
dle missing data, assuming that data are missing at ran-
dom. The dependent variable is the outcome measure
and the independent variables are time and group as-
signment and the interaction between these variables.
In these analyses, adjustments can be made for poten-
tially confounding variables that could be unequally
distributed over the groups despite the randomization
procedure.
To evaluate cost-effectiveness, direct (para)medical costs
and the total costs of all separate treatments by health
care providers during the intervention period will be
summed, as well as the costs of the facilities and materials
used for these treatments. In addition, the non-medical
costs, such as productivity loss, will be calculated. The
incremental cost-effectiveness ratio will be calculated by
dividing the difference in total costs by the difference in
Quality-adjusted Life Years (QALYs), based on the EQ-5D.
A net health-benefit analysis will be used to relate the
costs to the benefit. We assume that the economic value
of 1 life year in good health amounts to 25,000–50,000 €.
The economic evaluation will be performed following the
Dutch guidelines [53].
Discussion
The present study focuses on the effect of tDCS provided
during SLT in the sub-acute stage after stroke. The pri-
mary aim is to evaluate the potential effect of tDCS on
language functioning, specifically on word-finding, as
well as generalization effects to verbal communication.
The secondary aim is to evaluate its effect on social
participation and quality of life, and to evaluate the
cost-effectiveness of this intervention.
In line with studies applying tDCS in the chronic stage,
we use the most common electrode configuration, i.e., an-
odal tDCS over the left IFG as compared to sham-tDCS,
in combination with disorder-oriented aphasia therapy,
aimed at word-finding. The application of tDCS (1 mA for
20 minutes) and the frequency is also chosen in line with
studies applying tDCS in the chronic stage. However, the
discussion of what may be the optimal electrode configur-
ation and what the optimal stimulation intensity and fre-
quency is, is still ongoing. Regarding the optimal electrode
configuration, individual factors such as lesion size and
the relative contribution of the RH and the LH and its re-
lation to aphasia recovery, may lead to individual variabil-
ity in response to tDCS. However, recent fMRI and
computer modeling studies find that applying anodal
tDCS on the left IFG [30–32] may be a suitable approach.
We expect that tDCS will enhance the speed of lan-
guage recovery, resulting in improved communication,
quality of life and participation – associated with de-
creased rehabilitation consumption and cost reduction.
If we find that tDCS enhances the effect of SLT in an early
phase provided that adverse effects are limited at this stage
post stroke, and if it is found to be cost-effective, tDCS
may be implemented in regular aphasia rehabilitation
programs for the sub-acute post-stroke population.
Trial status
The inclusion of the study started on 17 April 2014 and
on 2 May 2016 we had included 44 participants. We ex-
pect that the inclusion and the follow-up measurements
will be completed in April 2017.
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